Palladium will provide you with the concepts and capabilities you require to outperform your competitors in this ultra-competitive field.
The pharmaceutical and life sciences industries are at a strategic crossroads. Drug costs continue to rise while patent expirations of top-selling drugs are fast-approaching, causing potential revenue shortfalls. Numerous other issues exist in safety and efficacy, political and economic issues, and cost pressures on tax payers and private payers. In result, fewer opportunities exist to capitalize on blockbuster drugs.
Our experience and sound approach can help you tackle challenges such as:
- Balancing the value of your product pipeline while improving the efficiency of product development
- Exploiting opportunities and efficiencies through mergers & acquisitions, licenesing, and post merger integration
- Building capabilities in strategic areas such as marketing and sales that are more efficient and effective
- Managing strategic alliances to drive growth and improve chances of success
Palladium Case Study
Merck's Path to the Palladium Balanced Scorecard Hall of Fame
Facing daunting challenges (including important patent expiries), a pharmaceutical giant defined a new strategy and forged a new strategy management infrastructure to leverage its strengths. Executed through the BSC, the new strategy has boosted sales, stock price, and clinical cycle times—and facilitated post merger integration. Click here to read the full article.
Contact our practice to learn more about the ways which we can help you.